{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T02:13:45Z","timestamp":1788315225909,"version":"build-2803163510"},"reference-count":41,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.vaccine.2024.02.022","type":"journal-article","created":{"date-parts":[[2024,2,17]],"date-time":"2024-02-17T09:04:00Z","timestamp":1708160640000},"page":"1928-1933","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Hospitalizations of patients with herpes zoster in Poland during 2012\u20132021: A population-based study"],"prefix":"10.1016","volume":"42","author":[{"given":"Micha\u0142","family":"Rz\u0105d","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krzysztof","family":"Kanecki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2996-583X","authenticated-orcid":false,"given":"Katarzyna","family":"Lewtak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3793-7214","authenticated-orcid":false,"given":"Piotr","family":"Tyszko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pawe\u0142","family":"Gorynski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aneta","family":"Nitsch-Osuch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.vaccine.2024.02.022_b0005","doi-asserted-by":"crossref","first-page":"192","DOI":"10.3390\/v14020192","article-title":"Herpes zoster: a review of clinical manifestations and management","volume":"14","author":"Patil","year":"2022","journal-title":"Viruses"},{"issue":"6 Suppl","key":"10.1016\/j.vaccine.2024.02.022_b0010","doi-asserted-by":"crossref","first-page":"S130","DOI":"10.1016\/j.jaad.2007.08.046","article-title":"Herpes zoster: epidemiology, natural history, and common complications","volume":"57","author":"Weinberg","year":"2007","journal-title":"J Am Acad Dermatol"},{"issue":"23","key":"10.1016\/j.vaccine.2024.02.022_b0015","first-page":"00140","article-title":"Herpes zoster ophthalmicus: frequency and risk factors for developing uncommon ocular manifestations","volume":"S0008\u20134182","author":"Dmitriev","year":"2023","journal-title":"Can J Ophthalmol"},{"issue":"5","key":"10.1016\/j.vaccine.2024.02.022_b0020","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1097\/ICL.0000000000000591","article-title":"Herpes zoster ophthalmicus review and prevention","volume":"45","author":"Davis","year":"2019","journal-title":"Eye Contact Lens"},{"key":"10.1016\/j.vaccine.2024.02.022_b0025","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ajo.2021.02.002","article-title":"Herpes zoster ophthalmicus clinical presentation and risk factors for loss of vision","volume":"226","author":"Niederer","year":"2021","journal-title":"Am J Ophthalmol"},{"issue":"5","key":"10.1016\/j.vaccine.2024.02.022_b0030","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1007\/s00405-021-07136-2","article-title":"Ramsay Hunt syndrome with multiple cranial neuropathy: a literature review","volume":"279","author":"Ananthapadmanabhan","year":"2022","journal-title":"Eur Arch Otorhinolaryngol"},{"issue":"4","key":"10.1016\/j.vaccine.2024.02.022_b0035","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1097\/00007890-200202270-00023","article-title":"Disseminated varicella infection in adult renal allograft recipients: four cases and a review of the literature","volume":"73","author":"Fehr","year":"2002","journal-title":"Transplantation"},{"issue":"6","key":"10.1016\/j.vaccine.2024.02.022_b0040","doi-asserted-by":"crossref","first-page":"502","DOI":"10.3390\/v11060502","article-title":"Current in vivo models of varicella-zoster virus neurotropism","volume":"11","author":"Mahalingam","year":"2019","journal-title":"Viruses"},{"issue":"4","key":"10.1016\/j.vaccine.2024.02.022_b0045","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1007\/s13365-020-00857-w","article-title":"Determinants of neurological syndromes caused by varicella zoster virus (VZV)","volume":"26","author":"Kennedy","year":"2020","journal-title":"J Neurovirol"},{"issue":"6","key":"10.1016\/j.vaccine.2024.02.022_b0050","doi-asserted-by":"crossref","first-page":"e004833","DOI":"10.1136\/bmjopen-2014-004833","article-title":"Systematic review of incidence and complications of herpes zoster: towards a global perspective","volume":"4","author":"Kawai","year":"2014","journal-title":"BMJ Open"},{"issue":"3","key":"10.1016\/j.vaccine.2024.02.022_b0055","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1097\/QCO.0000000000000647","article-title":"Central nervous system infections produced by varicella zoster virus","volume":"33","author":"Nagel","year":"2020","journal-title":"Curr Opin Infect Dis"},{"issue":"3","key":"10.1016\/j.vaccine.2024.02.022_b0060","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.jaad.2020.06.1013","article-title":"Risk of recurrent herpes zoster in a population-based cohort study of older adults","volume":"85","author":"Qian","year":"2021","journal-title":"J Am Acad Dermatol"},{"issue":"12 Suppl 2","key":"10.1016\/j.vaccine.2024.02.022_b0065","doi-asserted-by":"crossref","first-page":"S429","DOI":"10.1093\/infdis\/jiab387","article-title":"Herpes Zoster Vaccines","volume":"224","author":"Harbecke","year":"2021","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2024.02.022_b0070","unstructured":"[Announcement of the Minister of Health dated December 11, 2023 on the list of reimbursed drugs, foodstuffs for special nutritional purposes and medical devices for January 1, 2024.]; https:\/\/www.gov.pl\/web\/zdrowie\/obwieszczenie-ministra-zdrowia-z-dnia-11-grudnia-2023-r-w-sprawie-wykazu-refundowanych-lekow-srodkow-spozywczych-specjalnego-przeznaczenia-zywieniowego-oraz-wyrobow-medycznych; accessed 12.01.2024."},{"key":"10.1016\/j.vaccine.2024.02.022_b0075","unstructured":"Kuchar E, Rudnicka L, Kocot-K\u0119pska M, Nitsch-Osuch A, Rejdak K, et al. [Vaccination against herpes zoster. Recommendations of the expert group of the Polish Society of Vaccinology, the Polish Society of Family Medicine, the Polish Society of Dermatology, the Polish Society for the Study of Pain, and the Polish Society of Neurology]. Med. Prakt. 5: 64-72."},{"issue":"15","key":"10.1016\/j.vaccine.2024.02.022_b0080","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1186\/s12889-015-1753-y","article-title":"Herpes zoster-associated mortality in Europe: a systematic review","volume":"5","author":"Bricout","year":"2015","journal-title":"BMC Public Health"},{"issue":"18","key":"10.1016\/j.vaccine.2024.02.022_b0085","doi-asserted-by":"crossref","first-page":"3501","DOI":"10.1016\/j.vaccine.2019.11.054","article-title":"The burden of herpes zoster disease in Norway","volume":"38","author":"Mirinaviciute","year":"2020","journal-title":"Vaccine"},{"issue":"8","key":"10.1016\/j.vaccine.2024.02.022_b0090","doi-asserted-by":"crossref","first-page":"e0255877","DOI":"10.1371\/journal.pone.0255877","article-title":"Herpes zoster epidemiology in Latin America: a systematic review and meta-analysis","volume":"16","author":"Bardach","year":"2021","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.vaccine.2024.02.022_b0095","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1186\/1471-2334-11-173","article-title":"Herpes zoster in Germany: quantifying the burden of disease","volume":"16","author":"Ultsch","year":"2011","journal-title":"BMC Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2024.02.022_b0100","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1186\/s12879-017-2688-y","article-title":"Hospitalizations realted to herpes zoster infection in the Canary Islands, Spain (2005\u20132014)","volume":"17","author":"Garc\u00eda-Rojas","year":"2017","journal-title":"BMC Infect Dis"},{"issue":"9","key":"10.1016\/j.vaccine.2024.02.022_b0105","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.3390\/ijerph6092344","article-title":"Herpes zoster associated hospital admissions in Italy: review of the hospital discharge forms","volume":"6","author":"Gabutti","year":"2009","journal-title":"Int J Environ Res Public Health"},{"issue":"13","key":"10.1016\/j.vaccine.2024.02.022_b0110","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1186\/1471-2334-13-586","article-title":"Disease burden of herpes zoster in Sweden\u2013predominance in the elderly and in women - a register based study","volume":"12","author":"Studahl","year":"2013","journal-title":"BMC Infect Dis"},{"issue":"4","key":"10.1016\/j.vaccine.2024.02.022_b0115","article-title":"The burden of Herpes Zoster and its complications in Poland in according to the age","volume":"69","author":"Albrecht","year":"2015","journal-title":"Przegl Epidemiol"},{"key":"10.1016\/j.vaccine.2024.02.022_b0120","first-page":"32","article-title":"Threat of herpes zoster and its complications in Poland against the possibility of prevention by vaccination","volume":"4","author":"Albrecht","year":"2023","journal-title":"Terapia"},{"key":"10.1016\/j.vaccine.2024.02.022_b0125","unstructured":"TIBCO Software Inc. Statistica (Data Analysis Software System), Version 13. http:\/\/statistica.io. 2017."},{"key":"10.1016\/j.vaccine.2024.02.022_b0130","doi-asserted-by":"crossref","unstructured":"Abramson JH. WINPEPI updated: computer programs for epidemiologists, and their teaching potential. Epidemiol Persp. 2011; 8: 1.","DOI":"10.1186\/1742-5573-8-1"},{"key":"10.1016\/j.vaccine.2024.02.022_b0135","unstructured":"Statistics Poland. https:\/\/stat.gov.pl; [Accessed 04 February 2023]."},{"issue":"16","key":"10.1016\/j.vaccine.2024.02.022_b0140","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/s12879-016-1369-6","article-title":"Hospital-based herpes zoster diagnoses in Denmark: rate, patient characteristics, and all-cause mortality","volume":"1","author":"Schmidt","year":"2016","journal-title":"BMC Infect Dis"},{"issue":"3","key":"10.1016\/j.vaccine.2024.02.022_b0145","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.jinf.2016.05.008","article-title":"The burden of hospitalisation for varicella and herpes zoster in England from 2004 to 2013","volume":"73","author":"Hobbelen","year":"2016","journal-title":"J Infect"},{"issue":"50","key":"10.1016\/j.vaccine.2024.02.022_b0150","doi-asserted-by":"crossref","first-page":"7933","DOI":"10.1016\/j.vaccine.2010.09.074","article-title":"Herpes zoster: Burden of disease in France","volume":"28","author":"Gonzalez Chiappe","year":"2010","journal-title":"Vaccine"},{"issue":"12","key":"10.1016\/j.vaccine.2024.02.022_b0155","doi-asserted-by":"crossref","first-page":"3645","DOI":"10.1002\/jmv.26008","article-title":"Varicella-zoster virus infection in the pediatric population with acute lymphoblastic leukemia in Poland","volume":"92","author":"Zawitkowska","year":"2020","journal-title":"J Med Virol"},{"issue":"1","key":"10.1016\/j.vaccine.2024.02.022_b0160","doi-asserted-by":"crossref","first-page":"5930","DOI":"10.1038\/s41467-022-33686-y","article-title":"Trends in non-COVID-19 hospitalizations prior to and during the COVID-19 pandemic period, United States, 2017\u20132021","volume":"13","author":"Cassell","year":"2022","journal-title":"Nat Commun"},{"issue":"12","key":"10.1016\/j.vaccine.2024.02.022_b0165","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1016\/j.mayocp.2017.10.009","article-title":"Risk factors for herpes zoster: a systematic review and meta-analysis","volume":"92","author":"Kawai","year":"2017","journal-title":"Mayo Clin Proc"},{"issue":"1","key":"10.1016\/j.vaccine.2024.02.022_b0170","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S0950268803001523","article-title":"Gender difference in the incidence of shingles","volume":"132","author":"Fleming","year":"2004","journal-title":"Epidemiol Infect"},{"issue":"1","key":"10.1016\/j.vaccine.2024.02.022_b0175","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1186\/s12879-022-07479-z","article-title":"Prevalence of and factors associated with herpes zoster in England: a cross-sectional analysis of the Health Survey for England","volume":"22","author":"Cadogan","year":"2022","journal-title":"BMC Infect Dis"},{"issue":"14","key":"10.1016\/j.vaccine.2024.02.022_b0180","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1186\/1471-2458-14-1098","article-title":"Herpes zoster vaccine (HZV): utilization and coverage 2009\u20132013, Alberta, Canada","volume":"23","author":"Liu","year":"2014","journal-title":"BMC Public Health"},{"issue":"2","key":"10.1016\/j.vaccine.2024.02.022_b0185","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.jinf.2014.08.018","article-title":"Incidence of herpes zoster and its complications in Germany, 2005\u20132009","volume":"70","author":"Hillebrand","year":"2015","journal-title":"J Infect"},{"issue":"3","key":"10.1016\/j.vaccine.2024.02.022_b0190","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.jinf.2016.11.005","article-title":"Herpes zoster as a marker of occult cancer: a systematic review and meta-analysis","volume":"74","author":"Schmidt","year":"2017","journal-title":"J Infect"},{"issue":"6","key":"10.1016\/j.vaccine.2024.02.022_b0195","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1089\/pop.2012.1563","article-title":"Nutritional factors in herpes zoster, postherpetic neuralgia, and zoster vaccination","volume":"15","author":"Chen","year":"2012","journal-title":"Popul Health Manag"},{"issue":"22","key":"10.1016\/j.vaccine.2024.02.022_b0200","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1056\/NEJMoa1501184","article-title":"Efficacy of an adjuvanted herpes zoster subunit vaccine in older adults","volume":"372","author":"Lal","year":"2015","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.vaccine.2024.02.022_b0205","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1056\/NEJMoa1603800","article-title":"Efficacy of the herpes zoster subunit vaccine in adults 70 years of age or older","volume":"375","author":"Cunningham","year":"2016","journal-title":"N Engl J Med"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X24001695?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X24001695?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,6]],"date-time":"2024-05-06T10:40:51Z","timestamp":1714992051000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X24001695"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":41,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["S0264410X24001695"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2024.02.022","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hospitalizations of patients with herpes zoster in Poland during 2012\u20132021: A population-based study","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2024.02.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}